Terminated OBSERVATIONAL NCT03078829

The Relation of GnRH Treatment to QTc Interval in Transgender Females

The Relation of GnRH Treatment to QTc Interval in Transgender Female Youth: A Time Series Study

Sponsor: University of California, San Francisco

Interventions Treatment with a GnRh agonists

Updated 7 times since 2017 Last updated: Dec 21, 2018 Started: May 1, 2017 Primary completion: Aug 21, 2017 Completion: Aug 21, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

investigator has left UCSF

Other terminated trials from University of California, San Francisco

See all terminations from University of California, San Francisco

Other Gender Dysphoria trials with similar outcome

Browse all Gender Dysphoria trials

A observational or N/A phase clinical study on Gender Dysphoria, this trial is terminated or withdrawn. The trial is conducted by University of California, San Francisco and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jan 2019 — Jan 2021 [monthly]

Terminated

Status: Recruiting → Terminated
Jun 2018 — Jan 2019 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
May 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States